Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Elanco Animal Health (ELAN)
NYSE:ELAN
Elanco Animal Health (ELAN) Stock Price & Analysis
315 Followers
ELAN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$8.52 - $18.80
Previous Close$12.72
Volume4.61M
Average Volume (3M)5.27M
Market Cap
$6.29B
Enterprise Value$11.71B
Total Cash (Recent Filing)$352.00M
Total Debt (Recent Filing)$5.77B
Price to Earnings (P/E)―
Beta1.74
Next Earnings
Aug 08, 2024EPS Estimate
$0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.64
Shares Outstanding494,181,620
10 Day Avg. Volume3,080,868
30 Day Avg. Volume5,272,574
Standard Deviation0.13
R-Squared0.33
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-2.65
Price to Sales (P/S)2.02
Price to Cash Flow (P/CF)14.20
P/FCF Ratio11.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.65
Enterprise Value/Gross Profit4.71
Enterprise Value/Ebitda-46.65
Forecast
1Y Price Target
$18.63Price Target Upside46.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
Elanco Animal Health News
PremiumCompany Announcements
Elanco Animal Health Finalizes Aquaculture Sale for $1.3B
PremiumPress Releases
Elanco Completes Sale of Aqua Business
PremiumThe Fly
Elanco falls -22.0%
PremiumThe Fly
Elanco falls -19.0%Bulls Say, Bears Say
Bulls Say
Product PipelineElanco remains optimistic about Zenrelia's blockbuster potential and its contribution to the innovative portfolio.
Revenue TargetsManagement expects to achieve a $600M-$700M innovation gross revenue target by the end of 2025.
Stock PerformanceELAN shares sharply outperformed (+25% vs. S&P flat) as the company provided clarity and specific timing for anticipated approvals of its three key pipeline drugs.
Bears Say
Financial PerformanceRevenue expectations for Zenrelia have been lowered by 50% across 2024-2027 due to concerns about the black box warning.
Market AdoptionVeterinarians are likely to be reluctant to adopt Zenrelia into their practice meaningfully owing to the warning.
Regulatory ChallengesZenrelia received a black-box label warning from the FDA, creating challenges.
---
Ownership Overview
0.77% Insiders
48.77% Mutual Funds
14.52% Other Institutional Investors
35.95% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ELAN FAQ
What was Elanco Animal Health’s price range in the past 12 months?
Elanco Animal Health lowest stock price was $8.52 and its highest was $18.80 in the past 12 months.
What is Elanco Animal Health’s market cap?
Currently, no data Available
When is Elanco Animal Health’s upcoming earnings report date?
Elanco Animal Health’s upcoming earnings report date is Aug 08, 2024 which is in 17 days.
How were Elanco Animal Health’s earnings last quarter?
Elanco Animal Health released its earnings results on May 08, 2024. The company reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.274 by $0.066.
Is Elanco Animal Health overvalued?
According to Wall Street analysts Elanco Animal Health’s price is currently Undervalued.
Does Elanco Animal Health pay dividends?
Elanco Animal Health does not currently pay dividends.
What is Elanco Animal Health’s EPS estimate?
Elanco Animal Health’s EPS estimate is $0.24.
How many shares outstanding does Elanco Animal Health have?
Elanco Animal Health has 494,181,600 shares outstanding.
What happened to Elanco Animal Health’s price movement after its last earnings report?
Elanco Animal Health reported an EPS of $0.34 in its last earnings report, beating expectations of $0.274. Following the earnings report the stock price went up 24.926%.
Which hedge fund is a major shareholder of Elanco Animal Health?
Among the largest hedge funds holding Elanco Animal Health’s share is Dodge & Cox. It holds Elanco Animal Health’s shares valued at 1B.
---
Elanco Animal Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$18.63 (46.46% Upside)
$18.63 (46.46% Upside)
Blogger Sentiment
Bullish
ELAN Sentiment 66%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 1.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $254.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.1%
Last 30 Days ▲ 20.3%
Last 30 Days ▲ 20.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
7.61%
12-Months-Change
Fundamentals
Return on Equity
-19.24%
Trailing 12-Months
Asset Growth
-11.10%
Trailing 12-Months
Company Description
Elanco Animal Health
Elanco Animal Health, Inc. engages in the innovation, development, manufacture and market products for companion and food animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded on May 3, 2018 and is headquartered in Greenfield, IN.
---
ELAN Company Deck
---
ELAN Earnings Call
Q1 2024
0:00 / 0:00
---
ELAN Stock 12 Month Forecast
Average Price Target
$18.63
▲(46.46% Upside)
Technical Analysis
Best Analysts Covering ELAN
1 Year
1 Year Success Rate
8/13 ratings generated profit
1 Year Average Return
+15.32%
assigned a buy rating 12 days ago
Copying Michael Ryskin's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of +15.32% per trade.
---